lead position
Patents
Features list
-
Companies working in the field of biotechnology could face limited protection for their inventions following the introduction of a revised patent law in Germany. Harald von Campenhausen outlines the pitfalls and how rights owners can best avoid them
-
US litigation is expensive and time-consuming, while USPTO reexamination provides limited involvement and grounds of attack for challengers. John Isacson explores proposed new legislation that promises to offer greater opportunities to patent challengers in the USPTO
-
MIP's latest survey of the largest IP practices in Asia, Europe and the US shows how a growing trend towards consolidation is re-shaping IP practices in many parts of the world
-
Two recent cases in the still blurred area of market dominance have left pharmaceutical companies holding their breath. Sophie Lawrance and Pat Treacy examine the cases and whether the way in which competition law is enforced is becoming an obstacle to the pharmaceutical industry's success
-
For its impact on patent owners, Phillips v AWH Corporation is one of the most important cases of the past decade. Thankfully, says Irv Feit, the Federal Circuit found a compromise between the competing approaches to claim interpretation
-
Mexico's patent regime had, until recently, created a situation that allowed untested generics to come to market. But, says Luis Schmidt, a recent change in the law should improve standards
Local Insights